Claire Mazumdar, 37 years of age, currently heads Bicara Therapeutics as its founder and CEO. The firm, which was incubated by Biocon and later listed on NASDAQ, went public in 2024 and now has a market valuation of over $1.6 billion.
Kiran Mazumdar-Shaw picks niece Claire Mazumdar as successor at Biocon: Report
You May Also Like
Posted in
All
Medical Student Stabbed To Death In Punjab: Cops
Posted by
avianscape.enterprises@gmail.com
Posted in
All
Cuba Warns Of “Bloodbath” If US Attacks
Posted by
avianscape.enterprises@gmail.com
More From Author
Posted in
All
Medical Student Stabbed To Death In Punjab: Cops
Posted by
avianscape.enterprises@gmail.com